It is approved by the U.S. Food and Drug Administration (FDA) for treating certain types of leukemia and is helpful in other conditions that require immunosuppressive therapy. (aamds.org)
Half of the patients treated in this study responded to either ponatinib (typically used for certain types of leukemia) or pazopinib (a kidney cancer drug), depending on the genetic alterations identified through sequencing. (sciencedaily.com)
The first gene therapies approved in the United States are treating patients with certain types of leukemia and lymphoma. (sciencenews.org)